Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,556,626
-$84,158 QoQ
Shares Held
5,171
+4.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#357
of 784 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Norinchukin Bank, The holds $23,476,207 across 6 Biotechnology names. ALNY ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,275 | $12,554,850 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,834 | $6,131,892 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
5,171 | $1,556,626 | |
| 4 | MRNA |
Moderna, Inc.
|
21,383 | $1,497,451 | |
| 5 | INCY |
Incyte Corp
|
9,401 | $1,065,697 | |
| 6 | TECH |
BIO-TECHNE Corp
|
9,479 | $669,691 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,556,626 | 5,171 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,640,784 | 4,959 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,784,255 | 4,487 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||